Biotest Aktiengesellschaft

WBAG:BIO3 Stock Report

Market Cap: €1.4b

Biotest Future Growth

Future criteria checks 4/6

Biotest is forecast to grow earnings and revenue by 29.3% and 3.6% per annum respectively while EPS is expected to grow by 29.4% per annum.

Key information

29.3%

Earnings growth rate

29.4%

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth rate3.6%
Future return on equityn/a
Analyst coverage

Low

Last updated09 Sep 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

WBAG:BIO3 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202571259N/AN/A1
12/31/2024636-4N/AN/A1
9/30/2024707695690N/A
6/30/202478116486119N/A
3/31/2024783177-1023N/A
12/31/2023685127-36-3N/A
9/30/202365691-122-93N/A
6/30/2023538-10-146-117N/A
3/31/2023517-47-127-98N/A
12/31/2022516-32-70-40N/A
9/30/2022505-69-414N/A
6/30/2022511-653049N/A
3/31/2022512-545169N/A
12/31/2021516-631634N/A
9/30/2021514-28-324N/A
6/30/2021507-33-32-5N/A
3/31/2021507-35-49-22N/A
12/31/2020484-31-44-17N/A
9/30/2020466-34-74-40N/A
6/30/2020459-24-83-49N/A
3/31/2020439-15-70-36N/A
12/31/2019419-5-68-34N/A
9/30/2019406-9-74-19N/A
6/30/2019395-3-61-6N/A
3/31/2019390-6-81-26N/A
12/31/2018400-13-105-50N/A
9/30/201840518-123-16N/A
6/30/20184096N/A6N/A
3/31/20184001N/A15N/A
12/31/2017378-16N/A34N/A
9/30/2017257-48N/A8N/A
6/30/2017301-47N/A-8N/A
3/31/2017340-29N/A35N/A
12/31/20164086N/A66N/A
9/30/2016531128N/A51N/A
6/30/201652552N/A57N/A
3/31/201652636N/A44N/A
12/31/201553527N/A38N/A
9/30/2015590-88N/A62N/A
6/30/20156063N/A54N/A
3/31/201560216N/A15N/A
12/31/201458219N/A-11N/A
9/30/201454327N/A-26N/A
6/30/201452231N/A-28N/A
3/31/201450430N/A-1N/A
12/31/201350132N/A-7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BIO3's forecast earnings growth (29.3% per year) is above the savings rate (1.4%).

Earnings vs Market: BIO3's earnings (29.3% per year) are forecast to grow faster than the Austrian market (8.8% per year).

High Growth Earnings: BIO3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BIO3's revenue (3.6% per year) is forecast to grow faster than the Austrian market (0.8% per year).

High Growth Revenue: BIO3's revenue (3.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if BIO3's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y